Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Helen Tracey"'
Autor:
Yuan Chen, Tamara D. Cabalu, Ernesto Callegari, Heidi Einolf, Lichuan Liu, Neil Parrott, Sheila Annie Peters, Edgar Schuck, Pradeep Sharma, Helen Tracey, Vijay V. Upreti, Ming Zheng, Andy Z.X. Zhu, Stephen D. Hall
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 9, Pp 685-695 (2019)
Regulatory agencies currently recommend itraconazole (ITZ) as a strong cytochrome P450 3A (CYP3A) inhibitor for clinical drug–drug interaction (DDI) studies. This work by an International Consortium for Innovation and Quality in Pharmaceutical Deve
Externí odkaz:
https://doaj.org/article/a909582f81534613a6810cda695e685b
Autor:
Alex Georgiou, Andrew W Harrell, Robert Wilson, Kunal S Taskar, Kylie Riddell, Maxine A. Taylor, Miriam Marotti, Helen Tracey, Aarti Patel, Anthony Cahn, Edith M. Hessel
Publikováno v:
Drug Metabolism and Disposition. 48:307-316
In vitro data for low-dose inhaled phosphoinositide 3-kinase delta inhibitor nemiralisib revealed that it was a substrate and a potent metabolism-dependent inhibitor of cytochrome P450 (P450) 3A4 and a P-glycoprotein (P-gp) substrate. An integrated i
Autor:
Lichuan Liu, Tamara D. Cabalu, Stephen D. Hall, Ernesto Callegari, Sheila Annie Peters, Andy Z. X. Zhu, Heidi J. Einolf, Yuan Chen, Pradeep Sharma, Helen Tracey, Vijay V. Upreti, Edgar Schuck, Neil Parrott, Ming Zheng
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 9, Pp 685-695 (2019)
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 9, Pp 685-695 (2019)
Regulatory agencies currently recommend itraconazole (ITZ) as a strong cytochrome P450 3A (CYP3A) inhibitor for clinical drug–drug interaction (DDI) studies. This work by an International Consortium for Innovation and Quality in Pharmaceutical Deve
Autor:
Adnan Khan, Farnaz Fallah-Arani, Bart Vanderhoydonck, Judi Charlotte Neuss, Sarah Malcolm, Alfred Lammens, Richard J. Franklin, Lindsay K. Shuttleworth, Qiuya Huang, Jamie Henshall, Daniel James Ford, Mi-Yeon Jang, Shengqiao Li, Helen Tracey Horsley, Daniel Christopher Brookings, Mark Waer, Rodger A. Allen, Payne Andrew Charles, Yuan Lin, Eleanor Ward, Tom Ceska, Piet Herdewijn, Mark Jairaj, James Thomas Reuberson, Stefan Steinbacher, Mark Daniel Calmiano, Carl Brendan Doyle, Ling-Jie Gao, William R. Pitt, Jean Herman, Martin Augustin, Thierry Louat, Anant Ramrao Ghawalkar
Publikováno v:
Journal of medicinal chemistry. 61(15)
The primary target of a novel series of immunosuppressive 7-piperazin-1-ylthiazolo[5,4- d]pyrimidin-5-amines was identified as the lipid kinase, PI4KIIIβ. Evaluation of the series highlighted their poor solubility and unwanted off-target activities.
Autor:
Robyn Fowler, Helen Tracey Horsley, Franco H. Falcone, Cameron Alexander, Driton Vllasaliu, Martin C. Garnett, Snow Stolnik, Bryan Smith
Publikováno v:
Journal of Controlled Release
Non-invasive delivery of biotherapeutics, as an attractive alternative to injections, could potentially be achieved through the mucosal surfaces, utilizing nanoscale therapeutic carriers. However, nanoparticles do not readily cross the mucosal barrie
Autor:
Paul M. Savina, Joseph W. Polli, Eri Kanaoka, Grant T. Generaux, James D. Clarke, Kelly A. Harmon, Helen Tracey, Melinda J. Reese, Joan E. Humphreys, Lindsey O. Webster
Publikováno v:
Drug Metabolism and Disposition. 41:353-361
Dolutegravir (DTG; S/GSK1349572) is a potent HIV-1 integrase inhibitor with a distinct resistance profile and a once-daily dose regimen that does not require pharmacokinetic boosting. This work investigated the in vitro drug transport and metabolism
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines
Autor:
Stephen Robert Mack, Trevor Morgan, William R. Pitt, Lewis Gowers, Helen Lightfoot, Sara Wright, Helen Tracey Horsley, Christopher James Lock, Gavin Bennett, Verity Margaret Sabin, Claire Louise Kulisa, Rikki Peter Alexander, Verity Q Dale, Tom Ceska, Karen Viviane Lucile Crépy, Anne-Lise Nicolas, Benjamin Ian Perry, Tom Crabbe, Kerry Jenkins, George M. Buckley, Lynwen A. James
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:4700-4704
The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
Autor:
Helen Tracey Horsley, Ian Whitcombe, Driton Vllasaliu, Snow Stolnik, Martin C. Garnett, Francisco Fernández Trillo, Bryan Ronain Smith, Robyn Fowler, Mike Eaton, Cameron Alexander
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 9(19)
The understanding and control of nanoparticle transport into and through cellular compartments is central to biomedical applications of nanotechnology. Here, it is shown that the transport pathway of 50 nm polystyrene nanoparticles decorated with vit
Autor:
Brian Edgar Looker, Peter R. Butchers, Peter J. Mutch, Iain Mcfarlane Mclay, Alison J. Ford, Duncan S. Holmes, Claire E. Smith, Philip Charles Box, Inderjit Singh Mann, Helen Tracey Horsley, Richard Conroy, Valerie S. Morrison, Fern Kerr, Nicola Bevan, Amanda Emmons, Victoria J. Barrett, Panayiotis A. Procopiou, Anne-Marie Li-Kwai-Cheung, Paula Tomlin, Diane Mary Coe, Keith Biggadike
Publikováno v:
Journal of medicinal chemistry. 53(11)
A series of saligenin beta(2) adrenoceptor agonist antedrugs having high clearance were prepared by reacting a protected saligenin oxazolidinone with protected hydroxyethoxyalkoxyalkyl bromides, followed by removal of the hydroxy-protecting group, al
Publikováno v:
ChemInform. 40
Starting from commercially available (S)-glycidol, and via a common intermediate, the total synthesis of (−)-histrionicotoxin 285A and (−)-perhydrohistrionicotoxin has been achieved. Key to this synthesis was the efficient construction of a six-m